Literature DB >> 6623578

Macular edema: a major complication of diabetic retinopathy.

F L Ferris, A Patz.   

Abstract

Entities:  

Mesh：

Year:  1983        PMID： 6623578

Source DB:  PubMed          Journal:  Trans New Orleans Acad Ophthalmol        ISSN： 0077-8605


× No keyword cloud information.
  6 in total

1.  Oral minocycline for the treatment of diabetic macular edema (DME): results of a phase I/II clinical study.

Authors:  Catherine A Cukras; Philip Petrou; Emily Y Chew; Catherine B Meyerle; Wai T Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-22       Impact factor: 4.799

2.  Novel nanoparticulate gel formulations of steroids for the treatment of macular edema.

Authors:  Sai H S Boddu; Jwala Jwala; Ravi Vaishya; Ravinder Earla; Pradeep K Karla; Dhananjay Pal; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2010-02       Impact factor: 2.671

3.  The effect of intravitreal bevacizumab on ocular blood flow in diabetic retinopathy and branch retinal vein occlusion as measured by laser speckle flowgraphy.

Authors:  Fumihiko Nitta; Hiroshi Kunikata; Naoko Aizawa; Kazuko Omodaka; Yukihiro Shiga; Masayuki Yasuda; Toru Nakazawa
Journal:  Clin Ophthalmol       Date:  2014-06-11

Review 4.  Laser-based strategies to treat diabetic macular edema: history and new promising therapies.

Authors:  Young Gun Park; Eun Yeong Kim; Young Jung Roh
Journal:  J Ophthalmol       Date:  2014-09-22       Impact factor: 1.909

5.  High-resolution, in vivo multimodal photoacoustic microscopy, optical coherence tomography, and fluorescence microscopy imaging of rabbit retinal neovascularization.

Authors:  Wei Zhang; Yanxiu Li; Van Phuc Nguyen; Ziyi Huang; Zhipeng Liu; Xueding Wang; Yannis M Paulus
Journal:  Light Sci Appl       Date:  2018-12-05       Impact factor: 17.782

6.  Oral Dextromethorphan for the Treatment of Diabetic Macular Edema: Results From a Phase I/II Clinical Study.

Authors:  David J Valent; Wai T Wong; Emily Y Chew; Catherine A Cukras
Journal:  Transl Vis Sci Technol       Date:  2018-12-17       Impact factor: 3.283
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.